Welcome to This Week in Urology. This week we're covering 10 notable papers spanning stone disease and lithotripsy technology, prostate cancer screening and diagnosis, and a cluster of surgical and functional urology studies that ask whether newer technique really beats older technique. Let's dive in.

This week's papers:

1. Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0. — BJU International 2026
2. Potassium Citrate vs Thiazides for Empiric Stone Prevention: A Propensity-Matched Analysis. — Urology 2026
3. Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro). — European Urology Focus 2026
4. Detection of Clinically-Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Series. — Urology 2026
5. Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration. — The Journal of Urology 2026
6. Efficacy and safety of thulium fiber laser versus conventional holmium:YAG laser in anatomical endoscopic enucleation of the prostate: a systematic review and pairwise meta-analysis. — World Journal of Urology 2026
7. Transabdominal lumbar approach (TALA) versus retroperitoneal approach for robot-assisted renal surgery: a prospective randomised controlled trial. — World Journal of Urology 2026
8. Randomized Trial of Percutaneous Versus Transcutaneous Tibial Nerve Stimulation in The Treatment of Refractory Overactive Bladder: Results From The TRANSPER Trial. — Neurourology and Urodynamics 2026
9. Side-specific lower detrusor apron-sparing robot-assisted radical prostatectomy: functional and oncological outcomes. — World Journal of Urology 2026
10. Comparison of ultrasonic lithotripsy with Ho:YAG laser lithotripsy during percutaneous nephrolithotomy for 20-40 mm low-hardness renal calculi: a propensity score-matched study. — World Journal of Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning advanced prostate cancer systemic therapy and molecular imaging, the surgical management of bladder outflow obstruction and stone disease, and a set of studies that challenge long-standing perioperative habits. Let's dive in.

This week's papers:

1. Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform. — European Urology 2026
2. PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer. — European Urology Focus 2026
3. Blue Laser Vaporization for Benign Prostatic Hyperplasia: A Prospective Cohort Study on Efficacy and Preservation of Ejaculation. — European Urology Focus 2026
4. Prostate surgery outcomes in patients presenting with and without a urethral catheter: a long-term comparative study. — World Journal of Urology 2026
5. Single-port robotic prostatectomy is associated with higher same-day discharge and reduced length of stay: a NSQIP analysis. — World Journal of Urology 2026
6. Suction-assisted ureteroscopy compared with traditional ureteroscopy for renal stones ≤ 2 cm: a systematic review, Bayesian network meta-analysis and meta-regression. — World Journal of Urology 2026
7. The effect of prestenting on the success rates of endourological stone surgery in children. — World Journal of Urology 2026
8. Perioperative Management of Direct Oral Anticoagulants in Urological Surgery: The Prospective PAUSE-URO Study. — European Urology Focus 2026
9. Screening for Asymptomatic Bacteriuria Before Cystoscopy: A Systematic Review and Meta-analysis. — European Urology Focus 2026
10. Contemporary Trends in Primary Retroperitoneal Lymph Node Dissection in Nonseminomatous Germ Cell Tumors. — European Urology Focus 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning bladder and prostate cancer management, the cardiometabolic care of men on androgen deprivation, and a cluster of stone and benign prostate papers that touch everything from stent size to climate. Let's dive in.

This week's papers:

1. 2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline. — The Journal of Urology 2026
2. Rising active surveillance rates/observation and regimen intensification in young men: A retrospective cohort study of national commercial health insurance claims data. — Urology 2026
3. Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases. — Prostate Cancer and Prostatic Diseases 2026
4. Comparative effectiveness of apalutamide-, abiraterone-, and enzalutamide-based doublets in mHSPC. — BJU International 2026
5. Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial. — JAMA Internal Medicine 2026
6. Temporal and Geographic Trends in Surgical Management of Benign Prostatic Hyperplasia in the United States Veteran Population. — Urology 2026
7. Tolerability of 4.7Fr versus 6Fr ureteral stents following intracorporeal lithotripsy: a single center, patient- and assessor-blinded randomized controlled trial. — World Journal of Urology 2026
8. Optimal duration of pre-stenting before RIRS: a prospective randomized study evaluating FANS-UAS placement success. — World Journal of Urology 2026
9. Kidney stones composition prediction using artificial intelligence (KiSCAI) study. — BJU International 2026
10. Heat Index and Kidney Stone Recurrence Among Patients with Nephrolithiasis in a Veterans Affairs Population. — Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning functional and reconstructive outcomes after prostate cancer treatment, the evolving surgical and pharmacologic management of benign prostatic hyperplasia, and a set of practical questions in uro-oncology and perioperative care. Let's dive in.

This week's papers:

1. The 24-mo Outcomes from the Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER) — European Urology Focus 2026
2. Aligning Terminology and Assessment in Male Lower Urinary Tract Symptoms: A Comparison of Guideline Perspectives — European Urology Focus 2026
3. Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared to Buccal Mucosa Graft Onlay after Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis — The Journal of Urology 2026
4. Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy — The Journal of Urology 2026
5. Clinical Implications of Discordant Urinalysis and Urine Culture Findings Before Urologic Surgery — Urology 2026
6. The Association of 5-α Reductase Inhibitors for Benign Prostatic Hyperplasia with Development of Male Breast Disease and Erectile Dysfunction: A Retrospective Cohort Study of TriNetX Database — Urology 2026
7. Cost-Effectiveness of Contemporary Surgical Treatment Options for Benign Prostatic Hyperplasia — Urology 2026
8. Metallic versus polymeric ureteric stents for chronic malignant ureteric obstruction: a systematic review and meta-analysis — World Journal of Urology 2026
9. Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy — Prostate Cancer and Prostatic Diseases 2026
10. Sexual function after prostate cancer surgery or radiotherapy in an international registry — BJU International 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning benign prostatic obstruction and the surgical management of the prostate, advanced prostate cancer risk stratification and therapy, and a cluster of studies on peri-operative practice — imaging, antibiotics, opioids, and even remote robotic surgery. Let's dive in.

This week's papers:

1. Water Vapor Thermal Therapy with Rezūm Versus Combination Pharmacotherapy for Male Lower Urinary Tract Symptoms due to Benign Prostatic Obstruction: 1-Yr Results From a Prospective, Multicenter, Pragmatic Randomized Controlled Trial (VAPEUR-RCT) — European Urology Focus 2026
2. Practical Clinical Consultation Guide to Radioligand Therapy in Prostate Cancer — European Urology Focus 2026
3. Should We Send TURP Histology for Pathological Examination? — European Urology Focus 2026
4. Integrating NCCN and LATITUDE in metastatic castration-sensitive prostate cancer: a TITAN analysis — World Journal of Urology 2026
5. Urological issues in masculinising genital surgery: a Delphi consensus study — BJU International 2026
6. Inguinal/pelvic lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT — BJU International 2026
7. Safety and feasibility of telesurgical robot assisted radical prostatectomy: prospective pilot study — BJU International 2026
8. Emergency holmium laser enucleation of the prostate for management of refractory hematuria — World Journal of Urology 2026
9. Post-operative Urinary Tract Infection After Pediatric Pyeloplasty: A Multicenter Analysis of Drain Type, Surgical Approach, and Prophylactic Antibiotics — Urology 2026
10. Discharge Opioid Prescription After Outpatient Urologic Surgery Is Associated With Increased Risk of Opioid Refills: A Retrospective Cohort Study — Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning advanced genitourinary oncology and biomarkers, localised prostate cancer treatment selection, and reconstructive, functional and stone surgery. Let's dive in.

This week's papers:

1. Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial — The Lancet 2026
2. Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial — JAMA 2026
3. Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial — European Urology 2026
4. Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer — BJU International 2026
5. Flexible Ureteroscopy Versus Minipercutaneous Nephrolithotomy for 2 to 4 cm Renal Stones: A Systematic Review and Meta-Analysis — Journal of Endourology 2026
6. PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study — European Urology 2026
7. Second Time's a Charm? A Matched Case-Control Analysis of Revision Urethroplasty versus Primary Urethroplasty — The Journal of Urology 2026
8. Laparoscopic Burch Colposuspension Versus Transobturator Tape for the Treatment of Stress Urinary Incontinence in Egyptian Women: A 12-Month Randomized Controlled Trial — Neurourology and Urodynamics 2026
9. Prognostic Value of Perioperative Circulating Tumor DNA in Pure Urothelial Carcinoma and Histological Subtypes of Bladder Cancer — European Urology Focus 2026
10. Urethral calculi indications and outcomes of surgical management: a systematic review by EAU endourology — World Journal of Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we are covering ten notable papers spanning new clinical guidelines, updates in urologic oncology, and innovations in endourology and functional urology. Let us dive in.

This week's papers:

1. Medical Management of Kidney Stones: AUA Guideline (2026) Part I: Evaluation of Patients with Kidney Stones and Dietary Management of Patients with Calcium Stones — The Journal of Urology 2026
2. Medical Management of Kidney Stones: AUA Guideline (2026) Part II: Treatment and Follow-Up of Kidney Stones — The Journal of Urology 2026
3. Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis — European Urology 2026
4. Discordant Response in Pelvic Lymph Nodes and Cystectomy Specimens After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer — European Urology Focus 2026
5. Retrograde intrarenal surgery with flexible and navigable suction access sheaths vs mini-percutaneous nephrolithotomy for large upper urinary tract stones: a systematic review and meta-analysis — BJU International 2026
6. Intra-corporeal robot-assisted versus open radical cystectomy: a meta-analysis — World Journal of Urology 2026
7. Predictors of success and failure in outpatient ureteral stenting under local anaesthesia: a systematic review and proposed clinical guide from EAU Endourology — World Journal of Urology 2026
8. The impact of prostate size on outcomes of aquablation: a prospective study — World Journal of Urology 2026
9. Preoperative Tumor Shape Irregularity Is Associated With Pathological Upstaging to pT3 in Clinical T1 Renal Cell Carcinoma Treated With Partial or Radical Nephrectomy — International Journal of Urology 2026
10. Transcutaneous tibial neuromodulation, is the future of neuromodulation here? — World Journal of Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 7 notable papers spanning urothelial oncology, functional urology and reconstruction, and advanced prostate cancer and health services. Let's dive in.

This week's papers:

1. Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer — The New England Journal of Medicine 2026
2. Robot-assisted artificial urinary sphincter implantation via a posterior vesicovaginal approach for female stress urinary incontinence due to intrinsic sphincter deficiency: mid-term outcomes from a prospective single-centre study — World Journal of Urology 2026
3. What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer — European Urology 2026
4. Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial — European Urology Focus 2026
5. Preoperative factors associated with surgical complexity in pelvic fracture urethral injury: Systematic review — Urology 2026
6. Non-Invasive Triage of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms: A Narrative Review and Conceptual Framework for Depth-Aware Multimodal Transcutaneous Testing — Neurourology and Urodynamics 2026
7. Sustained Rise in Vasectomy Rates After Dobbs v. Jackson: A nationwide analysis using Epic Cosmos — Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning major guideline updates in oncology, emerging strategies in bladder cancer, and new clinical data in functional and endourology. Let's dive in.

This week's papers:

1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. — European urology 2026
2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer. — European urology 2026
3. EAU Guidelines on Nonmuscle-invasive Bladder Cancer (TaT1 and CIS) - A Summary of the 2026 Guidelines Update. — European urology 2026
4. Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026). Part II: Evaluation and Management of Metastatic Castration-Resistant Prostate Cancer. — The Journal of urology 2026
5. Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer. — The Journal of urology 2026
6. European Association of Urology Guidelines on Urological Infections: Summary of the 2026 Guidelines. — European urology 2026
7. European Association of Urology Guidelines on Neuro-urology: Summary of the 2026 Update. — European urology 2026
8. Omitting catheterization after ureteroscopic lithotripsy: a prospective, multicenter, randomized controlled trial. — World journal of urology 2026
9. Novel BCG Combination or Modified BCG Regimens in BCG-Naïve High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. — European urology focus 2026
10. Endoscopic Outlet Surgery versus Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders. — Urology 2026

Listen at AudioScholar

Welcome to This Week in Urology. This week we're covering 10 notable papers spanning prostate cancer diagnostic pathways and advanced therapeutics, reconstructive strategies for urethral disease, and optimization techniques in functional urology. Let's dive in.

This week's papers:

1. ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy. — European urology 2026
2. Informed Decision Making for Prostate Cancer Screening - A Prospective, Randomized Study of Two Novel Web-based, Electronic Visits. — The Journal of urology 2026
3. Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study. — BJU international 2026
4. Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. — European urology focus 2026
5. Advances in systemic therapies for advanced prostate cancer. — BMJ 2026
6. Prostate morcellation devices: a systematic review and meta-analysis of clinical outcomes and efficiency. — BJU international 2026
7. Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center. — Neurourology and urodynamics 2026
8. Self-management of Male LUTS. — European urology focus 2026
9. Contemporary Review of Pelvic Fracture Urethral Injury Management and Outcomes. — European urology focus 2026

Listen at AudioScholar